BRADLEY FOSTER & SARGENT INC/CT - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 908 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.

Quarter-by-quarter ownership
BRADLEY FOSTER & SARGENT INC/CT ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,776,9600.0%37,4290.0%0.08%0.0%
Q2 2023$3,776,960
+9.0%
37,429
-0.7%
0.08%
-4.8%
Q1 2023$3,466,468
+0.3%
37,679
-1.1%
0.08%
-4.6%
Q4 2022$3,457,430
+15.6%
38,111
-3.2%
0.09%
+4.8%
Q3 2022$2,991,000
-12.2%
39,353
-2.4%
0.08%
-5.7%
Q2 2022$3,408,000
-7.1%
40,318
-3.5%
0.09%
+12.8%
Q1 2022$3,667,000
-7.0%
41,793
-7.3%
0.08%
-4.9%
Q4 2021$3,945,000
-7.2%
45,102
-13.3%
0.08%
-18.0%
Q3 2021$4,252,000
-24.4%
51,996
-15.7%
0.10%
-24.2%
Q2 2021$5,624,000
-52.5%
61,644
-55.5%
0.13%
-56.0%
Q1 2021$11,849,000
-27.2%
138,621
-19.6%
0.30%
-30.2%
Q4 2020$16,283,000
+7.9%
172,438
-0.6%
0.43%
-2.7%
Q3 2020$15,087,000
-2.6%
173,493
-7.6%
0.44%
-28.7%
Q1 2020$15,487,000
-12.1%
187,829
+0.9%
0.62%
+14.0%
Q4 2019$17,619,000
+3.8%
186,069
-4.7%
0.54%
-3.9%
Q3 2019$16,967,000
-1.2%
195,253
+3.9%
0.57%
-0.4%
Q2 2019$17,167,000
+3.8%
188,003
+9.3%
0.57%
-1.6%
Q1 2019$16,540,000
+14.1%
172,043
+1.9%
0.58%
-1.4%
Q4 2018$14,493,000
-2.7%
168,894
-2.3%
0.58%
+15.8%
Q3 2018$14,893,000
+7.9%
172,849
-5.4%
0.50%
+2.2%
Q2 2018$13,801,000
-8.3%
182,704
-1.8%
0.49%
-13.5%
Q1 2018$15,044,000
-4.3%
186,073
-0.7%
0.57%0.0%
Q4 2017$15,728,000
-3.5%
187,328
-1.3%
0.57%
-8.1%
Q3 2017$16,297,000
+1.7%
189,829
-1.2%
0.62%
-3.1%
Q2 2017$16,030,000
+8.6%
192,051
-3.4%
0.64%
+7.6%
Q1 2017$14,766,000
-27.0%
198,814
-28.4%
0.60%
-30.6%
Q4 2016$20,226,000
-49.5%
277,681
-45.2%
0.86%
-51.0%
Q3 2016$40,016,000
-5.0%
506,794
-0.7%
1.75%
-7.2%
Q2 2016$42,106,000
+11.5%
510,314
-2.1%
1.89%
+7.6%
Q1 2016$37,756,000
-13.5%
521,208
+2.7%
1.75%
-12.3%
Q4 2015$43,653,000
-5.5%
507,357
+0.9%
2.00%
-12.2%
Q3 2015$46,205,000
-5.0%
502,670
+1.6%
2.28%
+2.6%
Q2 2015$48,654,000
+0.6%
494,755
+0.9%
2.22%
+0.7%
Q1 2015$48,348,000
+13.0%
490,294
+6.2%
2.20%
+9.4%
Q4 2014$42,776,000
-1.4%
461,646
+0.1%
2.01%
-2.3%
Q3 2014$43,401,000
+1.9%
461,072
-2.0%
2.06%
-0.6%
Q2 2014$42,589,000
+4.9%
470,443
-1.5%
2.07%
-1.5%
Q1 2014$40,609,000
+8.9%
477,644
+3.0%
2.11%
+6.3%
Q4 2013$37,289,000
+5.8%
463,913
+0.9%
1.98%
-3.6%
Q3 2013$35,259,000
+10.1%
459,642
+1.5%
2.06%
+4.0%
Q2 2013$32,015,000452,7591.98%
Other shareholders
NOVARTIS A G shareholders Q1 2017
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders